IMPLANTABLE CARDIOVERTER-DEFIBRILLATOR (ICD) SYSTEM INCLUDING SUBSTERNAL LEAD

    公开(公告)号:US20220249855A1

    公开(公告)日:2022-08-11

    申请号:US17661103

    申请日:2022-04-28

    Abstract: Substernal implantable cardioveter-defibrillator (ICD) systems and methods for providing substernal electrical stimulation therapy to treat malignant tachyarrhythmia, e.g., ventricular tachycardia (VT) and ventricular fibrillation (VF) are described. In one example, an implantable cardioveter-defibrillator (ICD) system includes an ICD implanted in a patient and an implantable medical electrical lead. The lead includes an elongated lead body having a proximal end and a distal portion, a connector at the proximal end of the lead body configured to couple to the ICD, and one or more electrodes along the distal portion of the elongated lead body. The distal portion of the elongated lead body of the lead is implanted substantially within an anterior mediastinum of the patient and the ICD is configured to deliver electrical stimulation to a heart of the patient using the one or more electrodes.

    DRY ELECTRODES IN A WEARABLE GARMENT

    公开(公告)号:US20220225937A1

    公开(公告)日:2022-07-21

    申请号:US17152328

    申请日:2021-01-19

    Abstract: A wearable garment and an arrangement of electrodes configured to measure bioelectrical signals from a patient. The dry electrodes are free from adhesives to hold the electrodes in place on the patient's skin. The arrangement of the electrodes may be configured to limit noise and facilitate accurate signal sensing from the patient even with some amount of relative movement between the electrodes and the patient's skin. The wearable garment may be controllable to change the amount of compression based on the sensed signals from the electrodes, and from other sensors. The garment may maintain a comfortable level of compression until processing circuitry detects a signal of interest, such as a cardiac arrhythmia, irregular respiration, or some other signal. The processing circuitry may cause the wearable garment to increase compression to improve the contact between the electrodes and the patient's skin and improve reception of the measured signals.

    System and method for identifying and responding to P-wave oversensing in a cardiac system

    公开(公告)号:US11135441B2

    公开(公告)日:2021-10-05

    申请号:US16449883

    申请日:2019-06-24

    Abstract: A cardiac medical system, such as an implantable cardioverter defibrillator (ICD) system, receives a cardiac electrical signal by and senses cardiac events when the signal crosses an R-wave sensing threshold. The system determines at least one sensed event parameter from the cardiac electrical signal for consecutive cardiac events sensed by the sensing circuit and compares the sensed event parameters to P-wave oversensing criteria. The system detects P-wave oversensing in response to the sensed event parameters meeting the P-wave oversensing criteria; and adjusts at least one of an R-wave sensing control parameter or a therapy delivery control parameter in response to detecting the P-wave oversensing.

    Substernal leadless electrical stimulation system

    公开(公告)号:US10668270B2

    公开(公告)日:2020-06-02

    申请号:US14261488

    申请日:2014-04-25

    Abstract: Implantable leadless cardiac pacing systems and methods for providing substernal pacing using the leadless cardiac pacing systems are described. In one embodiment, an implantable leadless cardiac pacing system includes a housing, a first electrode on the housing, a second electrode on the housing, and a pulse generator within the housing and electrically coupled to the first electrode and the second electrode. The housing is implanted substantially within an anterior mediastinum of a patient and the pulse generator is configured to deliver pacing pulses to a heart of the patient via a therapy vector formed between the first and second electrodes.

    IMPLANTABLE CARDIOVERTER-DEFIBRILLATOR (ICD) SYSTEM INCLUDING SUBSTERNAL LEAD

    公开(公告)号:US20200069952A1

    公开(公告)日:2020-03-05

    申请号:US16678365

    申请日:2019-11-08

    Abstract: Substernal implantable cardioveter-defibrillator (ICD) systems and methods for providing substernal electrical stimulation therapy to treat malignant tachyarrhythmia, e.g., ventricular tachycardia (VT) and ventricular fibrillation (VF) are described. In one example, an implantable cardioveter-defibrillator (ICD) system includes an ICD implanted in a patient and an implantable medical electrical lead. The lead includes an elongated lead body having a proximal end and a distal portion, a connector at the proximal end of the lead body configured to couple to the ICD, and one or more electrodes along the distal portion of the elongated lead body. The distal portion of the elongated lead body of the lead is implanted substantially within an anterior mediastinum of the patient and the ICD is configured to deliver electrical stimulation to a heart of the patient using the one or more electrodes.

    ATRIAL ARRHYTHMIA EPISODE DETECTION IN A CARDIAC MEDICAL DEVICE
    47.
    发明申请
    ATRIAL ARRHYTHMIA EPISODE DETECTION IN A CARDIAC MEDICAL DEVICE 审中-公开
    心脏ARRHYTHMIA EPISODE检测在心脏医疗设备

    公开(公告)号:US20160213275A1

    公开(公告)日:2016-07-28

    申请号:US14604468

    申请日:2015-01-23

    Abstract: A method and medical device for detecting a cardiac event that includes sensing a cardiac signal, determining RR-intervals in response to the sensed cardiac signal, detecting a cardiac event in response to the RR-intervals, iteratively sensing a predetermined number of P-waves in response to detecting the cardiac event, and confirming the cardiac event in response to the iteratively sensed P-waves.

    Abstract translation: 一种用于检测心脏事件的方法和医疗装置,包括感测心脏信号,响应于感测的心脏信号确定RR间隔,响应于RR间隔检测心脏事件,迭代地感测预定数量的P波 响应于检测心脏事件,以及响应于迭代感测的P波确认心脏事件。

    SUBSTERNAL LEADLESS ELECTRICAL STIMULATION SYSTEM
    48.
    发明申请
    SUBSTERNAL LEADLESS ELECTRICAL STIMULATION SYSTEM 审中-公开
    子宫无电刺激系统

    公开(公告)号:US20140330331A1

    公开(公告)日:2014-11-06

    申请号:US14261488

    申请日:2014-04-25

    Abstract: Implantable leadless cardiac pacing systems and methods for providing substernal pacing using the leadless cardiac pacing systems are described. In one embodiment, an implantable leadless cardiac pacing system includes a housing, a first electrode on the housing, a second electrode on the housing, and a pulse generator within the housing and electrically coupled to the first electrode and the second electrode. The housing is implanted substantially within an anterior mediastinum of a patient and the pulse generator is configured to deliver pacing pulses to a heart of the patient via a therapy vector formed between the first and second electrodes.

    Abstract translation: 描述了可植入无引心心脏起搏系统和使用无引心心脏起搏系统提供下位起搏的方法。 在一个实施例中,可植入无引心心脏起搏系统包括壳体,壳体上的第一电极,壳体上的第二电极以及壳体内的脉冲发生器,并且电耦合到第一电极和第二电极。 壳体基本上植入患者的前纵隔中,并且脉冲发生器被配置为经由形成在第一和第二电极之间的治疗矢量将起搏脉冲输送到患者的心脏。

    IMPLANTABLE CARDIOVERTER-DEFIBRILLATOR (ICD) SYSTEM INCLUDING SUBSTERNAL LEAD
    49.
    发明申请
    IMPLANTABLE CARDIOVERTER-DEFIBRILLATOR (ICD) SYSTEM INCLUDING SUBSTERNAL LEAD 审中-公开
    可植入式除颤器(ICD)系统,包括后置引线

    公开(公告)号:US20140330327A1

    公开(公告)日:2014-11-06

    申请号:US14261470

    申请日:2014-04-25

    CPC classification number: A61N1/3962 A61N1/05 A61N1/3956

    Abstract: Substernal implantable cardioveter-defibrillator (ICD) systems and methods for providing substernal electrical stimulation therapy to treat malignant tachyarrhythmia, e.g., ventricular tachycardia (VT) and ventricular fibrillation (VF) are described. In one example, an implantable cardioveter-defibrillator (ICD) system includes an ICD implanted in a patient and an implantable medical electrical lead. The lead includes an elongated lead body having a proximal end and a distal portion, a connector at the proximal end of the lead body configured to couple to the ICD, and one or more electrodes along the distal portion of the elongated lead body. The distal portion of the elongated lead body of the lead is implanted substantially within an anterior mediastinum of the patient and the ICD is configured to deliver electrical stimulation to a heart of the patient using the one or more electrodes.

    Abstract translation: 描述了用于治疗恶性快速性心律失常,例如室性心动过速(VT)和心室颤动(VF)的基础植入式心脏除颤器(ICD)系统和用于提供次要电刺激治疗的方法。 在一个示例中,植入式心脏除颤器(ICD)系统包括植入患者体内的ICD和可植入医用电导线。 引线包括具有近端和远端部分的细长引线体,在引线本体的近端处的连接器,其被配置为耦合到ICD,以及沿着细长引线体的远端部分的一个或多个电极。 引线的细长引线体的远端部分基本上植入患者的前纵隔,并且ICD构造成使用一个或多个电极将电刺激递送到患者的心脏。

    SYSTEM AND METHOD FOR AVOIDING UNDERSENSING OF VENTRICULAR FIBRILLATION
    50.
    发明申请
    SYSTEM AND METHOD FOR AVOIDING UNDERSENSING OF VENTRICULAR FIBRILLATION 有权
    用于避免心脏纤维化不全的系统和方法

    公开(公告)号:US20140276160A1

    公开(公告)日:2014-09-18

    申请号:US13833171

    申请日:2013-03-15

    Abstract: A medical device and associated method for detecting and treating tachyarrhythmias acquires a cardiac signal using electrodes coupled to a sensing module. Cardiac events are sensed from the cardiac signal and a processing module computes a first morphology metric for each sensed cardiac event occurring during a time segment of the cardiac signal. The first morphology metrics corresponding to an event originating in a ventricular chamber are counted. The first processing module computes a second morphology metric for the time segment of the cardiac signal in response to the count of the first morphology metrics meeting a threshold number of events. The time segment is classified as a shockable segment in response to the second morphology metric meeting a detection criterion.

    Abstract translation: 用于检测和治疗快速性心律失常的医疗装置和相关联的方法使用耦合到感测模块的电极获取心脏信号。 从心脏信号感测心脏事件,并且处理模块计算在心脏信号的时间段期间发生的每个感测到的心脏事件的第一形态度量。 计算对应于起始于心室的事件的第一形态学指标。 第一处理模块响应于满足阈值数量事件的第一形态学量度的计数,计算心脏信号的时间段的第二形态度量。 响应于符合检测标准的第二形态度量,该时间段被分类为可震击段。

Patent Agency Ranking